Bioregenx (BRGX) Total Non-Current Liabilities (2021)
Bioregenx's quarterly Total Non-Current Liabilities came in at $151399.0 in Q4 2021.
Bioregenx has reported Total Non-Current Liabilities for 1 years, with the latest figure at $151399.0 in Q4 2021.
- For the quarter ending Q4 2021, Total Non-Current Liabilities changed N/A year-over-year to $151399.0; the trailing twelve-month figure through Dec 2021 stood at $151399.0 (changed N/A YoY), and the FY2021 full-year result was $151399.0, changed N/A from the prior year.
- Total Non-Current Liabilities for Q4 2021 stood at $151399.0.
- The five-year high for Total Non-Current Liabilities was $151399.0 in Q4 2021, with the low at $151399.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 1.72 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 4.20 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 1.12 Bn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 172.85 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 1.90 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 200.21 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 10.69 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 737.31 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 151,399.00 |